Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)

"Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)." Leukemia & Lymphoma, 57(1), pp. 199–200

Acknowledgements

The authors are grateful to Lamya Haddaoui (TumourBank for the Groupe Ouest Est d’Etude des Leucémies aiguës et Autres Maladies du Sang [GOELAMS], Hôpital Cochin, Paris) and Christophe Roumier (Tumour Bank for the Acute Leukemia French Association [ALFA] group, Centre Hospitalier Universitaire de Lille) for handling and storing patient samples. The work of all clinical research assistants of the GOELAMS and ALFA groups is also acknowledged here.

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

This work was supported by the French National Cancer Institute, the French Ministry of Health (hospital program for clinical research, 2006-0213), a grant from the Laurette Fugain Association and the translational research program (PRTK 2012-43-CARAMELE).

Supplementary material available online

Supplementary Table 1